Compare CORT & NTSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | NTSK |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 7.4B |
| IPO Year | N/A | 2025 |
| Metric | CORT | NTSK |
|---|---|---|
| Price | $35.60 | $17.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 14 |
| Target Price | ★ $111.00 | $27.08 |
| AVG Volume (30 Days) | 2.4M | ★ 3.1M |
| Earning Date | 02-25-2026 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | ★ $741,172,000.00 | $661,153,000.00 |
| Revenue This Year | $23.96 | $32.93 |
| Revenue Next Year | $43.40 | $23.16 |
| P/E Ratio | $43.73 | ★ N/A |
| Revenue Growth | 17.92 | ★ 62.49 |
| 52 Week Low | $32.99 | $16.57 |
| 52 Week High | $117.33 | $27.99 |
| Indicator | CORT | NTSK |
|---|---|---|
| Relative Strength Index (RSI) | 16.99 | N/A |
| Support Level | $32.99 | N/A |
| Resistance Level | $85.34 | N/A |
| Average True Range (ATR) | 4.09 | 0.00 |
| MACD | -5.91 | 0.00 |
| Stochastic Oscillator | 4.61 | 0.00 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
Netskope Inc is redefining the security and networking of cloud and AI. The company has formed a cloud-native platform that offers converged security and networking services to enable fast and secure AI, cloud, and web access at the edge.